^
Phase 1/2
Rapa Therapeutics LLC
Recruiting
Last update posted :
03/30/2023
Initiation :
08/01/2021
Primary completion :
01/01/2024
Completion :
12/31/2024
EGFR • ALK • BRCA
|
EGFR mutation • ALK translocation • BRCA mutation
|
carboplatin • paclitaxel • Torisel (temsirolimus) • sirolimus • RAPA-201